rs61734984

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001003787.4(STRADA):ā€‹c.508C>Gā€‹(p.Leu170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000694 in 1,614,006 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Synonymous variant affecting the same amino acid position (i.e. L170L) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.0036 ( 3 hom., cov: 32)
Exomes š‘“: 0.00039 ( 4 hom. )

Consequence

STRADA
NM_001003787.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.04
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008486122).
BP6
Variant 17-63710564-G-C is Benign according to our data. Variant chr17-63710564-G-C is described in ClinVar as [Benign]. Clinvar id is 468884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0036 (549/152306) while in subpopulation AFR AF= 0.0124 (514/41558). AF 95% confidence interval is 0.0115. There are 3 homozygotes in gnomad4. There are 270 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
STRADANM_001003787.4 linkuse as main transcriptc.508C>G p.Leu170Val missense_variant 8/13 ENST00000336174.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
STRADAENST00000336174.12 linkuse as main transcriptc.508C>G p.Leu170Val missense_variant 8/131 NM_001003787.4 P1Q7RTN6-1

Frequencies

GnomAD3 genomes
AF:
0.00358
AC:
545
AN:
152188
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00118
AC:
296
AN:
251224
Hom.:
2
AF XY:
0.000891
AC XY:
121
AN XY:
135780
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.000391
AC:
571
AN:
1461700
Hom.:
4
Cov.:
31
AF XY:
0.000323
AC XY:
235
AN XY:
727162
show subpopulations
Gnomad4 AFR exome
AF:
0.0128
Gnomad4 AMR exome
AF:
0.00148
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000989
Gnomad4 OTH exome
AF:
0.00106
GnomAD4 genome
AF:
0.00360
AC:
549
AN:
152306
Hom.:
3
Cov.:
32
AF XY:
0.00363
AC XY:
270
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.0124
Gnomad4 AMR
AF:
0.00177
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.000635
Hom.:
0
Bravo
AF:
0.00443
ESP6500AA
AF:
0.0134
AC:
59
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00135
AC:
164
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024STRADA: BS1, BS2 -
STRADA-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 12, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Polyhydramnios, megalencephaly, and symptomatic epilepsy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
23
DANN
Benign
0.92
DEOGEN2
Benign
0.057
.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Benign
-0.011
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.88
D;.;D;.;D;.;D;D;D;D;T;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0085
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.41
.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.33
.;.;N;.;.;N;.;.;N;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.084
Sift
Benign
0.48
.;.;T;.;.;T;.;.;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.56
.;.;T;T;.;T;.;.;T;T;.;.;.;.;.;.;.;T;T;.;.;.;.;.;T;.;.;.;.
Polyphen
0.95, 0.99, 0.0010, 0.98
.;P;D;B;P;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;B;.;.;.;.
Vest4
0.57, 0.55, 0.55, 0.57, 0.56, 0.62, 0.56
MVP
0.76
MPC
0.93
ClinPred
0.0098
T
GERP RS
4.6
Varity_R
0.22
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61734984; hg19: chr17-61787924; API